Trial intelligence / Profile preview

TCM Tan Re Qing for HFMD With CNS Infection

ChiCTR-TRC-10000947Phase 4Completed

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Jul 2010
Countries
1
01

Overview

Phase 4, randomised trial of tanreqing in Central nervous system infection (3 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Mortality, Time of fever clearance and 1 more. Started Jul 2010; status: completed.

02

Drugs

tanreqing
03

Conditions

Central nervous system infection

Beyond the preview

Go deeper on ChiCTR-TRC-10000947.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10000947.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call